A new weight-loss drug called Wegovy (semaglutide), which has been granted FDA approval in the US, is being heralded by some health experts as "groundbreaking," and a potential "game changer" in the growing epidemic of obesity. Professor Jeremy Krebs is an endocrinologist at the University of Otago's Department of Medicine. He joins the show to discuss the new so-called wonder drug.
New drug billed as 'game-changer' in obesity crisis Photo: World Obesity Federation
